New Jersey-based Quest Diagnostics Incorporated (DGX) provides diagnostic testing, information, and services. With a market cap of $17.2 billion, Quest Diagnostics operates through Diagnostic ...

For the fourth quarter of 2024, the Zacks Consensus Estimate for Quest Diagnostics’ revenues is pegged at $2.57 billion, indicating an increase of 12.4% from the year-ago reported figure. The Zacks ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Quest Diagnostics may be the preferred lab your health insurance, doctors, or specialists use for blood work or other samples. We’re reviewing its sub-brand Quest Health, from which you can order your ...

Secaucus, New Jersey-based Quest Diagnostics Incorporated (DGX) provides diagnostic testing and services in the United States ...

Quest Diagnostics gets reaffirmed as a buy for the 3rd time in a row. Key bullish drivers include organic growth, macro demand, strong profit margins among peers, and an investment-grade view from ...

Quest Diagnostics is a dominant player in the growing medical testing industry, offering consistent earnings and dividend growth with lower volatility. DGX benefits from secular tailwinds like aging ...

New Jersey-based Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic information services, offering a wide range of laboratory testing and data-driven healthcare insights. The ...